Fig. 6From: An immune-related lncRNA signature predicts prognosis and adjuvant chemotherapeutic response in patients with small-cell lung cancerCox regression analyses of the irlncRNA signature in the training and validation cohorts. a Univariate Cox regression analyses of the risk score and clinical parameters. b Multivariate Cox regression analyses of the risk score and clinical parametersBack to article page